Advertisement Hope Pharma introduces Nithiodote - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Hope Pharma introduces Nithiodote

US based Hope Pharmaceuticals has introduced Nithiodote as a treatment for acute cyanide poisoning.

Nithiodote is a new antodote that includes two medications that are packaged together, Sodium Nitrite Injection and Sodium Thiosulfate Injection.

Sodium nitrite helps to remove cyanide from cells and thereby restores cellular use of oxygen.

Sodium thiosulfate converts cyanide to a less toxic molecule that can be readily excreted in the urine.

The combination enhances the detoxification of cyanide compared to the individual effects of each.

Hope Pharma medical director Craig Sherman said unlike other medications, Nithiodote is ready stat since sodium nitrite and sodium thiosulfate are sterile solutions that can be administered immediately without delay.

"Sodium nitrite can be infused in as little as two minutes, and sodium thiosulfate can be infused immediately afterwards," Sherman said.